How can we assist you?

    Track Record

    Charles River Laboratories

    Van Doorne advised Charles River Laboratories International, Inc. (NYSE: CRL) on its acquisition of Brains On-Line, a leading contract research organisation (CRO) providing critical data that advances novel therapeutics for the treatment of central nervous system (CNS) diseases.

    With operations in San Francisco, the Netherlands, and Germany, Brains On-Line is considered the world’s premier provider of microdialysis for CNS research. Additionally, Brains On-Line offers sophisticated in vivo efficacy and pharmacokinetics testing to provide critical data required to advance potential CNS therapies through the development process.